Merck KGaA says FY profit to fall to lower half of target range
By Ludwig Burger FRANKFURT (Reuters) -Germany's diversified group Merck KGaA flagged that full-year operating earnings would likely be in the
2023-11-09 14:27
Merck signs $5.5 billion deal with Daiichi for cancer therapy development
TOKYO (Reuters) -Japan's Daiichi Sankyo announced on Friday a $5.5 billion agreement with Merck to jointly develop its three precision
2023-10-20 09:26
Germany's Merck flags steeper drop in earnings
By Ludwig Burger FRANKFURT (Reuters) -Germany's Merck KGaA on Thursday warned of a steeper earnings decline on a slump in
2023-08-03 13:47
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Moderna said on Wednesday it has begun enrolling patients in a late-stage study evaluating its personalised mRNA-based skin
2023-07-26 20:16
White House says it will win Merck lawsuit, defends Medicare drug negotiations
WASHINGTON The Biden administration is confident it will succeed in the courts against Merck & Co's lawsuit filed
2023-06-07 02:24
CEO of Germany's Merck: decoupling from China would be at huge economic cost
By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) -The CEO of German technology group Merck KGaA said that unravelling trade
2023-06-06 23:25
Merck sues US government to halt Medicare drug price negotiation
By Michael Erman NEW YORK (Reuters) -Merck & Co sued the U.S. government on Tuesday, seeking an injunction of the
2023-06-06 21:24
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
By Julie Steenhuysen CHICAGO Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the
2023-06-05 20:52